» Articles » PMID: 21291555

Musculoskeletal Comorbidities in Cardiovascular Disease, Diabetes and Respiratory Disease: the Impact on Activity Limitations; a Representative Population-based Study

Overview
Publisher Biomed Central
Specialty Public Health
Date 2011 Feb 5
PMID 21291555
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The purpose of this study was to quantify the contribution of comorbidity to activity limitations in populations with chronic cardiovascular disease, diabetes or respiratory disease (index conditions), with emphasis on musculoskeletal comorbidity (arthritis or back problems).

Methods: Analysis of the 2005 Canadian Community Health Survey 3.1 (age 20+ years, n = 115,915). Prevalence ratios for activity limitations in people with the index conditions and co-occurring musculoskeletal disease, adjusted for age, gender, and socioeconomic factors, were used to estimate population associated fractions (PAF).

Results: Comorbid arthritis and back problems significantly increased the risk of activity limitations across all index conditions with prevalence ratios of 1.60 and 1.46 for cardiovascular disease, 1.51 and 1.36 for diabetes, and 1.38 and 1.44 for respiratory disease for arthritis and back problems respectively. Arthritis and back problems accounted for at least 13% and 9% of activity limitations in the index populations.

Conclusions: While chronic musculoskeletal conditions are not always considered priorities in chronic disease prevention, they account for a substantial proportion of activity restrictions seen in people with cardiovascular disease, diabetes and respiratory disease, with implications for prevention and control strategies.

Citing Articles

Public Awareness and Attitudes Toward Lifestyle Modifications for Controlling Osteoarthritis and Their Relationship to Cardiovascular Risk Factors.

AlQarni R, Aldandan H, Alnahwi Z, Almusaylim D, AlQarni R, Alduraywish W Cureus. 2024; 16(9):e69344.

PMID: 39398683 PMC: 11471273. DOI: 10.7759/cureus.69344.


Antinociceptive Analysis of Natural Monoterpenes Eugenol, Menthol, Carvacrol and Thymol in a Zebrafish Larval Model.

Rocha C, Felix L, Monteiro S, Venancio C Pharmaceuticals (Basel). 2024; 17(4).

PMID: 38675417 PMC: 11054028. DOI: 10.3390/ph17040457.


Pulmonary Diseases in Older Patients: Understanding and Addressing the Challenges.

Joshi P Geriatrics (Basel). 2024; 9(2).

PMID: 38525751 PMC: 10961796. DOI: 10.3390/geriatrics9020034.


Investigation of Biopsychosocial Status, Fatigue, Sleep Quality, Alexithymia, Cognitive Functions, and Quality of Life in Behçet's Disease.

Gur Kabul E, Yenil S, Ulutas F, Basakci Calik B, Cobankara V Mediterr J Rheumatol. 2024; 34(4):436-442.

PMID: 38282923 PMC: 10815526. DOI: 10.31138/mjr.290823.ib.


Preventative and therapeutic potential of tocotrienols on musculoskeletal diseases in ageing.

Saud Gany S, Chin K, Tan J, Aminuddin A, Makpol S Front Pharmacol. 2023; 14:1290721.

PMID: 38146461 PMC: 10749321. DOI: 10.3389/fphar.2023.1290721.


References
1.
. Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation--United States, 2003-2005. MMWR Morb Mortal Wkly Rep. 2006; 55(40):1089-92. View

2.
Gijsen R, Hoeymans N, Schellevis F, Ruwaard D, Satariano W, van den Bos G . Causes and consequences of comorbidity: a review. J Clin Epidemiol. 2001; 54(7):661-74. DOI: 10.1016/s0895-4356(00)00363-2. View

3.
Beckett M, Weinstein M, Goldman N . Do health interview surveys yield reliable data on chronic illness among older respondents?. Am J Epidemiol. 2000; 151(3):315-23. DOI: 10.1093/oxfordjournals.aje.a010208. View

4.
Picavet H, van den Bos G . The contribution of six chronic conditions to the total burden of mobility disability in the Dutch population. Am J Public Health. 1997; 87(10):1680-2. PMC: 1381135. DOI: 10.2105/ajph.87.10.1680. View

5.
Hill C, Gill T, Taylor A, Daly A, Grande E, Adams R . Psychological factors and quality of life in arthritis: a population-based study. Clin Rheumatol. 2006; 26(7):1049-54. DOI: 10.1007/s10067-006-0439-3. View